The decoupling thesis was already tightening before this. GRANULES ₹766 (no move today), SENORES ₹1092 ( 8.4%), NEULANDLAB ₹17,200 ( 1.4%) , all three sit in the US pharma exports cohort and all three were holding structure through last week's crude shock. The Pentagon list accelerates what was already structurally moving. I keep watching whether the order-flow data confirms the CRDMO capability claim or if it's still a positioning trade.

🇺🇸 Pentagon names WuXi AppTec on Chinese military-linked firms list Indian CDMO stocks may benefit from China 1 shift: 1️⃣ Divi's Lab: Global leader in custom synthesis and peptide manufacturing 2️⃣ Syngene: End-to-end discovery, development and manufacturing platform 3️⃣ Sai Life Sciences: Pure-play CRDMO with strong innovator pharma exposure 4️⃣ Piramal Pharma: Large CDMO platform with significant US/EU presence 5️⃣ Neuland Lab: Strong complex API and custom manufacturing capabilities 👉🏻 Any shift in pharma outsourcing away from Chinese suppliers could create opportunities for Indian CDMO and CRDMO players #DIVISLAB #SYNGENE #SAILIFE #PPLPHARMA #NEULANDLAB

Best 100 performing stocks over the last 3 years, with highest CAGR - CUPID = 278.92% VMARCIND = 192.33% V2RETAIL = 188.48% GVT&D = 185.28% BSE = 175.15% SKYGOLD = 152.93% SIGMAADV = 140.96% JSLL = 130.07% WEBELSOLAR = 130.03% APOLLO = 128.75% SHAILY = 124.86% GALLANTT = 124.83% WOCKPHARMA = 123.57% POWERINDIA = 111.18% INA = 109.74% MCX = 108.57% PICCADIL = 106.67% FORCEMOT = 102.37% TARIL = 101.62% ANANDRATHI = 100.89% BBOX = 99.27% SGMART = 97.26% THANGAMAYL = 96.6% AIIL = 96.07% GRWRHITECH = 95.41% SHILCTECH = 88.43% PGIL = 84.75% PTCIL = 83.14% POCL = 83.02% HBLENGINE = 82.61% GMRP&UI = 82.22% ASHAPURMIN = 80.85% BLISSGVS = 80.45% NEULANDLAB = 80.34% GVPIL = 80.02% TDPOWERSYS = 79.4% STAR = 78.67% LLOYDSENT = 77.78% STLTECH = 77.04% SHAKTIPUMP = 76.81% GABRIEL = 76.75% ACUTAAS = 75.07% GRSE = 74.84% COCHINSHIP = 74.33% HSCL = 73.27% IIFLCAPS = 73% IMFA = 72.76% WELCORP = 72.27% MANORAMA = 72.14% MOTILALOFS = 71.72% LLOYDSME = 71.7% PRECWIRE = 71.55% CEINSYS = 70.23% AXISCADES = 70.05% LUMAXTECH = 69.72% APARINDS = 69.61% MAZDOCK = 68.83% WAAREERTL = 68.77% SCHNEIDER = 68.42% SOLARINDS = 68.01% HUBTOWN = 67.51% NATIONALUM = 67.3% GOKULAGRO = 67.02% HINDCOPPER = 66.78% SHRIPISTON = 66.39% BHEL = 66.19% KIRLOSENG = 65.54% SHILPAMED = 65.41% JAIBALAJI = 65.27% INDRAMEDCO = 64.88% TSFINV = 64.86% KPEL = 64.7% SARDAEN = 64.5% NAM-INDIA = 64.48% BANCOINDIA = 64.19% SKIPPER = 62.49% JAYNECOIND = 62.33% ZENTEC = 61.38% LAURUSLABS = 60.93% ADANIPOWER = 60.91% SUZLON = 60.61% AVL = 60.28% BALUFORGE = 59.58% GMDCLTD = 58.58% NAVA = 58.17% MTARTECH = 57.94% GODFRYPHLP = 57.89% ASTRAMICRO = 57.67% ARVIND = 57.59% MANINDS = 56.7% AMBER = 55.71% GPIL = 55.42% TVSHLTD = 55.38% SJS = 55.17% SUPRIYA = 54.64% CARTRADE = 53.7% VIJAYA = 52.03% PARAS = 51.85% HUDCO = 51.69%

Best 100 performing stocks over the last 3 years, with highest CAGR - CUPID = 278.92% VMARCIND = 192.33% V2RETAIL = 188.48% GVT&D = 185.28% BSE = 175.15% SKYGOLD = 152.93% SIGMAADV = 140.96% JSLL = 130.07% WEBELSOLAR = 130.03% APOLLO = 128.75% SHAILY = 124.86% GALLANTT = 124.83% WOCKPHARMA = 123.57% POWERINDIA = 111.18% INA = 109.74% MCX = 108.57% PICCADIL = 106.67% FORCEMOT = 102.37% TARIL = 101.62% ANANDRATHI = 100.89% BBOX = 99.27% SGMART = 97.26% THANGAMAYL = 96.6% AIIL = 96.07% GRWRHITECH = 95.41% SHILCTECH = 88.43% PGIL = 84.75% PTCIL = 83.14% POCL = 83.02% HBLENGINE = 82.61% GMRP&UI = 82.22% ASHAPURMIN = 80.85% BLISSGVS = 80.45% NEULANDLAB = 80.34% GVPIL = 80.02% TDPOWERSYS = 79.4% STAR = 78.67% LLOYDSENT = 77.78% STLTECH = 77.04% SHAKTIPUMP = 76.81% GABRIEL = 76.75% ACUTAAS = 75.07% GRSE = 74.84% COCHINSHIP = 74.33% HSCL = 73.27% IIFLCAPS = 73% IMFA = 72.76% WELCORP = 72.27% MANORAMA = 72.14% MOTILALOFS = 71.72% LLOYDSME = 71.7% PRECWIRE = 71.55% CEINSYS = 70.23% AXISCADES = 70.05% LUMAXTECH = 69.72% APARINDS = 69.61% MAZDOCK = 68.83% WAAREERTL = 68.77% SCHNEIDER = 68.42% SOLARINDS = 68.01% HUBTOWN = 67.51% NATIONALUM = 67.3% GOKULAGRO = 67.02% HINDCOPPER = 66.78% SHRIPISTON = 66.39% BHEL = 66.19% KIRLOSENG = 65.54% SHILPAMED = 65.41% JAIBALAJI = 65.27% INDRAMEDCO = 64.88% TSFINV = 64.86% KPEL = 64.7% SARDAEN = 64.5% NAM-INDIA = 64.48% BANCOINDIA = 64.19% SKIPPER = 62.49% JAYNECOIND = 62.33% ZENTEC = 61.38% LAURUSLABS = 60.93% ADANIPOWER = 60.91% SUZLON = 60.61% AVL = 60.28% BALUFORGE = 59.58% GMDCLTD = 58.58% NAVA = 58.17% MTARTECH = 57.94% GODFRYPHLP = 57.89% ASTRAMICRO = 57.67% ARVIND = 57.59% MANINDS = 56.7% AMBER = 55.71% GPIL = 55.42% TVSHLTD = 55.38% SJS = 55.17% SUPRIYA = 54.64% CARTRADE = 53.7% VIJAYA = 52.03% PARAS = 51.85% HUDCO = 51.69%

Best 100 performing stocks over the last 3 years, with highest CAGR - CUPID = 278.92% VMARCIND = 192.33% V2RETAIL = 188.48% GVT&D = 185.28% BSE = 175.15% SKYGOLD = 152.93% SIGMAADV = 140.96% JSLL = 130.07% WEBELSOLAR = 130.03% APOLLO = 128.75% SHAILY = 124.86% GALLANTT = 124.83% WOCKPHARMA = 123.57% POWERINDIA = 111.18% INA = 109.74% MCX = 108.57% PICCADIL = 106.67% FORCEMOT = 102.37% TARIL = 101.62% ANANDRATHI = 100.89% BBOX = 99.27% SGMART = 97.26% THANGAMAYL = 96.6% AIIL = 96.07% GRWRHITECH = 95.41% SHILCTECH = 88.43% PGIL = 84.75% PTCIL = 83.14% POCL = 83.02% HBLENGINE = 82.61% GMRP&UI = 82.22% ASHAPURMIN = 80.85% BLISSGVS = 80.45% NEULANDLAB = 80.34% GVPIL = 80.02% TDPOWERSYS = 79.4% STAR = 78.67% LLOYDSENT = 77.78% STLTECH = 77.04% SHAKTIPUMP = 76.81% GABRIEL = 76.75% ACUTAAS = 75.07% GRSE = 74.84% COCHINSHIP = 74.33% HSCL = 73.27% IIFLCAPS = 73% IMFA = 72.76% WELCORP = 72.27% MANORAMA = 72.14% MOTILALOFS = 71.72% LLOYDSME = 71.7% PRECWIRE = 71.55% CEINSYS = 70.23% AXISCADES = 70.05% LUMAXTECH = 69.72% APARINDS = 69.61% MAZDOCK = 68.83% WAAREERTL = 68.77% SCHNEIDER = 68.42% SOLARINDS = 68.01% HUBTOWN = 67.51% NATIONALUM = 67.3% GOKULAGRO = 67.02% HINDCOPPER = 66.78% SHRIPISTON = 66.39% BHEL = 66.19% KIRLOSENG = 65.54% SHILPAMED = 65.41% JAIBALAJI = 65.27% INDRAMEDCO = 64.88% TSFINV = 64.86% KPEL = 64.7% SARDAEN = 64.5% NAM-INDIA = 64.48% BANCOINDIA = 64.19% SKIPPER = 62.49% JAYNECOIND = 62.33% ZENTEC = 61.38% LAURUSLABS = 60.93% ADANIPOWER = 60.91% SUZLON = 60.61% AVL = 60.28% BALUFORGE = 59.58% GMDCLTD = 58.58% NAVA = 58.17% MTARTECH = 57.94% GODFRYPHLP = 57.89% ASTRAMICRO = 57.67% ARVIND = 57.59% MANINDS = 56.7% AMBER = 55.71% GPIL = 55.42% TVSHLTD = 55.38% SJS = 55.17% SUPRIYA = 54.64% CARTRADE = 53.7% VIJAYA = 52.03% PARAS = 51.85% HUDCO = 51.69%

Best 100 performing stocks over the last 3 years, with highest CAGR - CUPID = 278.92% VMARCIND = 192.33% V2RETAIL = 188.48% GVT&D = 185.28% BSE = 175.15% SKYGOLD = 152.93% SIGMAADV = 140.96% JSLL = 130.07% WEBELSOLAR = 130.03% APOLLO = 128.75% SHAILY = 124.86% GALLANTT = 124.83% WOCKPHARMA = 123.57% POWERINDIA = 111.18% INA = 109.74% MCX = 108.57% PICCADIL = 106.67% FORCEMOT = 102.37% TARIL = 101.62% ANANDRATHI = 100.89% BBOX = 99.27% SGMART = 97.26% THANGAMAYL = 96.6% AIIL = 96.07% GRWRHITECH = 95.41% SHILCTECH = 88.43% PGIL = 84.75% PTCIL = 83.14% POCL = 83.02% HBLENGINE = 82.61% GMRP&UI = 82.22% ASHAPURMIN = 80.85% BLISSGVS = 80.45% NEULANDLAB = 80.34% GVPIL = 80.02% TDPOWERSYS = 79.4% STAR = 78.67% LLOYDSENT = 77.78% STLTECH = 77.04% SHAKTIPUMP = 76.81% GABRIEL = 76.75% ACUTAAS = 75.07% GRSE = 74.84% COCHINSHIP = 74.33% HSCL = 73.27% IIFLCAPS = 73% IMFA = 72.76% WELCORP = 72.27% MANORAMA = 72.14% MOTILALOFS = 71.72% LLOYDSME = 71.7% PRECWIRE = 71.55% CEINSYS = 70.23% AXISCADES = 70.05% LUMAXTECH = 69.72% APARINDS = 69.61% MAZDOCK = 68.83% WAAREERTL = 68.77% SCHNEIDER = 68.42% SOLARINDS = 68.01% HUBTOWN = 67.51% NATIONALUM = 67.3% GOKULAGRO = 67.02% HINDCOPPER = 66.78% SHRIPISTON = 66.39% BHEL = 66.19% KIRLOSENG = 65.54% SHILPAMED = 65.41% JAIBALAJI = 65.27% INDRAMEDCO = 64.88% TSFINV = 64.86% KPEL = 64.7% SARDAEN = 64.5% NAM-INDIA = 64.48% BANCOINDIA = 64.19% SKIPPER = 62.49% JAYNECOIND = 62.33% ZENTEC = 61.38% LAURUSLABS = 60.93% ADANIPOWER = 60.91% SUZLON = 60.61% AVL = 60.28% BALUFORGE = 59.58% GMDCLTD = 58.58% NAVA = 58.17% MTARTECH = 57.94% GODFRYPHLP = 57.89% ASTRAMICRO = 57.67% ARVIND = 57.59% MANINDS = 56.7% AMBER = 55.71% GPIL = 55.42% TVSHLTD = 55.38% SJS = 55.17% SUPRIYA = 54.64% CARTRADE = 53.7% VIJAYA = 52.03% PARAS = 51.85% HUDCO = 51.69%

3) #NEULANDLAB

stock I am tracking For tomorrow #NEULANDLAB #JAYNECOIND #AYE Holding #NUVAMA, #HFCL, #MTARTECH

7/ Neuland Laboratories #neulandlab

🧪 Neuland Labs - FY26 results, pipeline update, and why the peptide bet is the real story here Q4 FY26 confirmed the thesis. Commercial CMS is compounding. Now let's look at what matters next. ____________ 🟩 FY26 FULL YEAR - SETTING THE BASE First time crossing ₹2,000 Cr. Operating leverage finally showed up at scale. - Revenue: ₹2,053 Cr ( 37% YoY) - EBITDA: ₹603 Cr ( 76% YoY) at 29.4% margin - PAT: ₹363 Cr ( 40% YoY) - EPS: ₹283 vs ₹202 last year - Net Debt: negative ₹157 Cr - net cash on balance sheet Commercial CMS revenue alone went from ₹511 Cr in FY25 to ₹1,146 Cr in FY26. Same fixed costs. More volume. Margins followed. ____________ ⚡ Q4 FY26 - THE BLOWOUT QUARTER Record quarter on every single line. Management was upfront that 40% EBITDA margin should not be extrapolated. - Revenue: ₹789 Cr ( 135% YoY) - EBITDA: ₹319 Cr ( 449% YoY) at 40.5% margin - PAT: ₹212 Cr ( 666% YoY) - EPS: ₹165 in a single quarter - Gross margin: 62.1% vs 56.3% in Q4FY25 - mix driven Q3FY26 was ₹448 Cr. Q4FY26 was ₹789 Cr. Same business, different quarter. This is the lumpiness management keeps flagging and they are right to flag it. ____________ 🔬 CMS PIPELINE - THE REAL COMPOUNDING ENGINE 98 total active projects as of Q4FY26. Commercial count is steady but revenue per project is scaling - that is the actual story. - Pre-clinical: 20 - Phase 1: 22 - Phase 2: 20 - Phase 3: 10 - Pre-Reg/Reg: 7 - Commercial: 19 Every molecule moving from Pre-Reg to Commercial is a multi-year revenue compounder. This funnel feeds FY28 and FY29. ____________ 💊 GDS SIDE - SOFTER BUT NOT BROKEN Management acknowledged GDS was subdued in FY26 and has deployed resources for recovery. - Prime: Ezetimibe and Mirtazapine were key - Ezetimibe likely to drive continued growth - Specialty: Paliperidone drag offset by Apixaban, Donepezil and Aripiprazole Sterile - New DMF filings FY26: Vonoprazan and Edoxaban ____________ 🧬 PEPTIDES - THE OPTIONALITY NOBODY IS PRICING RIGHT 16-18 years of in-house process chemistry R&D. The edge is not the facility - it is the process development capability for clinical-stage peptide APIs. - Peptide facility commissioning: July 2026 - on schedule per management - Active peptide programs: 8-10 across early and advanced stages - Global peptide API market: $6 Bn today to $14 Bn by 2030 at 18.5% CAGR - CDMO peptide market: $5-6 Bn opportunity per external consultants - Management view: peptides alone have potential to create another Neuland in scale ____________ 📋 WHAT MANAGEMENT SAID - FY27 AND BEYOND No formal guidance but the earnings call was reasonably direct. These are the calls worth tracking. - Revenue CAGR aspiration: 18-20% over a 5-year horizon - aspirational, not guaranteed - FY27 new CMS commercialization: 1 expected, 1-2 more possible after that - Lumpiness continues - assess over 10-12 quarters not individual quarters - Working capital days: 137 in Q4FY26 vs 107 in Q4FY25 - normalization expected in FY27 - Capacity: Units 1 and 2 at 85-90%, Unit 3 at 65% and ramping - Capex FY26: ₹397 Cr - free cash flow was negative ₹49 Cr despite ₹363 Cr PAT - ROCE will moderate as longer capex cycles begin - management comfortable with this ____________ 💰 VALUATIONS AT ₹17,088 (MKT CAP ₹21,924 Cr) Not cheap. The question is whether the pipeline quality justifies the premium at this entry point. - Trailing P/E on FY26 PAT ₹363 Cr: 60x - FY27 forward P/E on est. PAT ₹420-435 Cr: 50-52x - FY28 forward P/E on est. PAT ₹500-520 Cr: 42-44x At 50x forward you are paying for near-flawless execution on three things simultaneously - peptide ramp from H2FY27, FY27 volume delivery without a soft patch, and working capital converting profits into cash. Business quality is not the debate. Entry price is. ____________ ⚠️ KEY RISKS At 60x trailing these matter more than they did at 30x. - Customer concentration: top 5 customers at 68% of Q4FY26 revenue - Lumpiness is structural and will not go away as newer high-value molecules enter the mix - Middle East: raw material and freight costs being actively monitored - Free cash flow: negative ₹49 Cr in FY26 despite ₹363 Cr PAT - working capital drag is real ____________ 3-5 year story for investors who understand CDMO cycles. Not a momentum trade at current valuations. Views are personal. Not investment advice. DYOR. #NeulandLabs #NEULANDLAB #CDMO #IndiaPharma #APIStocks #Peptides #GLP1 #StockResearch #EquityResearch

5 companies looking strong on the chart. Keep 👀👀👀. Bookmark it for your study. Pepost for Max reach. Add it in your WL #norec #DYOR 1. #NEULANDLAB

Portfolio Update- Due to lack of strong moves in the broader watchlist and my holdings, I decided to take some profits home. Booked profits in #Apollo, #Bhel, #BajajCon, #HFCL, #AdaniPower. This takes equity curve to new highs. Some of these may have been cut prematurely and they may go further up from here but I wanted to take home profit due to lack of broader participation and strong moves I would have liked to see. If things gain traction will get back again. Currently holding positions - #ENRIN , #NEULANDLAB , #SENORES with open risk in all 3.

NEULANDLAB Patience is an important asset in trading. This could squat today too. Highly possible. But look at the price action. That tells the whole story. Tightness/Contraction being formed with volumes completely drying up. Taking good support from 10 and 21 EMA. I'm okay to give time for the stock to prove itself. If it remains stagnant for a week then maybe will consider to rotate the money into another opportunity.

If you had invested ₹1 lakh in 2013🤭 1. #NEULANDLAB = ₹100 Crore value now 🤯💥

Companies where the Q4 numbers were impressive we have tried to figure out the tailwinds , risks , Capex plans and the future opportunity - The idea is simple - when you understand the business, the sector tailwind, the earnings drivers and the management commentary, you stop reacting to every price move and start thinking like an investor. Garware Hi Tech Films - #GRWRHITECH - x.com/Sandeep_Majj/status/20… Gland Pharma #Gland - x.com/Sandeep_Majj/status/20… Mold-Tek Packaging Ltd - #MOLDTKPAC - x.com/Sandeep_Majj/status/20… Thermax - #THERMAX - x.com/Sandeep_Majj/status/20… Force Motors - #FORCEMOT - x.com/Sandeep_Majj/status/20… Neuland Laboratories Ltd #NeulandLab - x.com/Sandeep_Majj/status/20… Advanced Enzymes Technologies Ltd #ADVENZYMES - x.com/Sandeep_Majj/status/20…

NEULANDLAB In the pharma sector. Earnings past us. I see prior strong uptrend. 21 EMA surfer. Tight consolidation and volume drying up. Priming to breakout. Looking for a breakout with good volumes.

Day 25 of #DailyDeepDives 📊 #NEULANDLAB Notes ➡️ Base breakout EP ➡️ Base Formation → Tight bars EP Breakout ➡️ Clean & supportive volume action throughout the structure 👀 P.S. - Chart is from 2021 and shared purely for educational/study purposes.

#BSE Top 100 #Stocks on 2026-05-21 13:22 #TopStocks #StockMarket #Investing Name Grp CurrentRate Change% LENSKART, B, 500.00, 2.74 MTARTECH, A, 7636.65, 2.38 ENERGYINF, IF, 77.00, 0.39 HDFCBANK, A, 756.40, -0.41 JUBLFOOD, A, 437.10, -7.50 SBIN, A, 949.00, -0.24 APOLLO, A, 362.55, 1.64 RELIANCE, A, 1351.85, -0.58 BHARTIARTL, A, 1896.75, -0.45 APOLLOHOSP, A, 8338.10, 2.96 ICICIBANK, A, 1238.85, 0.11 HDFCLIFE, A, 615.75, 1.79 SAMMAANCAP, A, 154.95, 9.31 GVTD, A, 4858.60, 3.54 TIINDIA, A, 3027.15, 1.80 NEULANDLAB, A, 16565.40, -0.37 AXISBANK, A, 1248.95, -0.05 AMBER, A, 7580.00, 7.42 MARUTI, A, 13005.60, 0.07 NAUKRI, A, 926.00, -1.69 INFY, A, 1184.15, -1.06 DIXON, A, 11210.40, 1.97 MCX, A, 3332.75, -3.09 IDEA, A, 13.71, 0.96 TRITURBINE, A, 694.15, 5.54 BEL, A, 420.65, 1.75 KAYNES, A, 3105.85, 3.47 MAXHEALTH, A, 1096.70, 1.90 LT, A, 3924.25, 0.31 CHOLAFIN, A, 1506.50, -0.81 GRASIM, A, 3138.00, 5.59 MOTHERSON, A, 136.05, 2.83 POWERINDIA, A, 36502.00, 2.83 LIQUIDBEES, F, 1000.00, 0.00 ULTRACEMCO, A, 11459.00, 0.50 JKLAKSHMI, A, 624.95, -1.74 TDPOWERSYS, A, 1287.25, 4.50 SWIGGY, A, 251.80, -1.97 NTPC, A, 388.95, -0.92 NETWEB, A, 3772.25, -1.79 BAJFINANCE, A, 906.65, -1.86 ENRIN, B, 3602.40, 4.13 M&M, A, 3094.20, -0.90 ADANIENT, A, 2707.70, 0.10 HEROMOTOCO, A, 4969.20, 0.03 KOTAKBANK, A, 378.60, -1.19 GRSE, A, 2687.00, 1.47 ADANIGREEN, A, 1370.00, 0.50 ADANIPOWER, A, 220.10, -0.05 NSDL, B, 814.45, 0.05 TCS, A, 2323.65, -0.15 MANKIND, A, 2516.35, -2.59 ENTERO, B, 1308.35, 3.90 HSCL, A, 592.10, 1.72 PERSISTENT, A, 5010.25, -1.44 BOSCHLTD, A, 34975.20, -5.01 HAVELLS, A, 1205.00, -0.20 IRB, A, 22.78, 7.81 GROWW, B, 189.20, 0.40 ANGELONE, A, 339.70, 4.59 SANSERA, A, 2802.30, 12.76 ATGL, A, 635.05, 4.02 VEDL, A, 332.05, -0.54 INDIGRID, IF, 169.50, 0.30 ANTHEM, B, 776.55, -0.47 PNBHOUSING, A, 1065.00, 0.36 PROTEAN, A, 654.00, 20.00 CGPOWER, A, 866.25, 1.51 HONAUT, A, 35145.95, 16.48 HFCL, A, 144.20, 3.52 THERMAX, A, 4608.55, 4.37 BAJAJ-AUTO, A, 10715.00, 2.41 TMCV, B, 381.60, 0.47 INDIGO, A, 4426.00, 3.81 ADANIENSOL, A, 1345.90, -0.07 JPPOWER, A, 18.89, 3.06 HINDALCO, A, 1094.50, 0.79 BECTORFOOD, A, 179.25, 0.34 ITC, A, 307.20, -0.11 HCLTECH, A, 1170.25, 0.04 BHEL, A, 408.80, 0.09 LAURUSLABS, A, 1352.55, -0.64 GESHIP, A, 1719.25, 3.35 SUZLON, A, 53.16, 1.12 EMMVEE, B, 255.15, -2.03 TVSMNCRPS, F, 10.25, -0.10 WIPRO, A, 199.45, 1.17 HAL, A, 4368.00, 0.93 KFINTECH, A, 839.05, 1.32 YESBANK, A, 21.47, -2.41 SOLARINDS, A, 18392.75, 1.03 SHRIRAMFIN, A, 913.80, -1.04 TATASTEEL, A, 208.00, 0.46 CIANAGRO, T, 1448.90, 5.00 PETRONET, A, 268.40, 1.42 IPCALAB, A, 1638.30, -0.48 ATHERENERG, B, 894.75, -1.57 ADANIPORTS, A, 1788.10, 0.83 SILVERBEES, E, 250.70, -0.83 LUPIN, A, 2279.90, -0.15

If You Had Invested ₹1 Lakh Only 5 Years Ago… # NEULANDLAB =65.32 Lakhs (Now)

If You Had Invested ₹1 Lakh Only 5 Years Ago… # NEULANDLAB =65.32 Lakhs (Now)